𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Aflatoxin B1 and polycyclic aromatic hydrocarbon adducts, p53 mutations and p16 methylation in liver tissue and plasma of hepatocellular carcinoma patients

✍ Scribed by Yu-Jing Zhang; Pavel Rossner Jr.; Yu Chen; Meenakshi Agrawal; Qiao Wang; Lillian Wang; Habibul Ahsan; Ming-Whei Yu; Po-Huang Lee; Regina M. Santella

Publisher
John Wiley and Sons
Year
2006
Tongue
French
Weight
213 KB
Volume
119
Category
Article
ISSN
0020-7136

No coin nor oath required. For personal study only.

✦ Synopsis

Abstract

Elevated aflatoxin B~1~‐albumin adducts (AFB~1~‐Alb) have been associated with an increased risk for HCC development. However, there are no studies in humans, correlating albumin adducts in blood with liver DNA adducts. Forty frozen tumor tissues and 39 paired plasma samples from HCC patients were collected in Taiwan, to determine the relationship between albumin adducts in blood and DNA adducts in liver tissue as well as mutations in p53 and methylation of p16. AFB~1~‐ and polycyclic aromatic hydrocarbon (PAH)‐DNA adducts in tissue and albumin adducts in plasma were determined by immunohistochemistry and competitive ELISA, respectively. Plasma AFB~1~‐Alb adducts in subjects with low, medium and high levels of AFB~1~‐DNA adducts in tumor tissues were 51.0 ± 36.5, 70.5 ± 48.1 and 84.9 ± 48.2 fmol/mg, respectively (p~trend~ = 0.05). No significant correlation was found for PAH. Fourteen of 40 (36%) tissues were positive for mutant p53 protein by immunohistochemistry; 11 of 40 tissue DNA samples (28%) were positive for p53 mutations, but not their corresponding plasma DNAs. p16 was methylated in 24 of 40 (62%) tissues and 12 of 39 (32%) plasma DNAs. Significant correlations were observed between AFB~1~‐Alb adducts and p53 mutations and p16 methylation. These data suggest that genetic, epigenetic and environmental exposure biomarkers in plasma may help in estimating the risk for the development of HCC. © 2006 Wiley‐Liss, Inc.

📜 SIMILAR VOLUMES

Polycyclic aromatic hydrocarbon-DNA addu
Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls
✍ Shu-Yuan Chen; Li-Yu Wang; Ruth M. Lunn; Wei-Yann Tsai; Po-Huang Lee; Chue-Shue 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 421 KB 👁 1 views

## Abstract HCC is a common cancer and HBV and AFB~1~ are well‐documented, major risk factors. Epidemiologic studies have documented that cigarette smoking also contributes to the development of HCC. PAHs are ubiquitous environmental pollutants and products of incomplete combustion. They are presen

High frequency of promoter hypermethylat
High frequency of promoter hypermethylation of RASSF1A and p16 and its relationship to aflatoxin B1–DNA adduct levels in human hepatocellular carcinoma
✍ Yu-Jing Zhang; Habibul Ahsan; Yu Chen; Ruth M. Lunn; Li-Yu Wang; Shu-Yuan Chen; 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 154 KB

## Abstract Epigenetic changes in gene expression due to extensive CpG island methylation is now accepted as the main cause of inactivation of the __p16__ gene. More recently, it has been suggested that the human ras association domain family (RASSF) 1 gene, cloned from the lung tumor‐suppressor lo

Inactivation of the DNA repair gene O6-m
Inactivation of the DNA repair gene O6-methylguanine-DNA methyltransferase by promoter hypermethylation and its relationship to aflatoxin B1-DNA adducts and p53 mutation in hepatocellular carcinoma
✍ Yu-Jing Zhang; Yu Chen; Habibul Ahsan; Ruth M. Lunn; Po-Huang Lee; Chien-Jen Che 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 French ⚖ 237 KB

## Abstract O^6^‐methylguanine‐DNA methyltransferase (MGMT) is a repair protein that specifically removes promutagenic alkyl groups from the O^6^ position of guanine in DNA. __MGMT__ is transcriptionally silenced by promoter hypermethylation in several human cancers. Methylation‐specific PCR (MSP)